FDA Approved: ZELBORAF — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Zelboraf (vemurafenib) submitted by Genentech, indicating an approved change to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Zelboraf (vemurafenib)

Snippet

SUPPL AP for ZELBORAF (VEMURAFENIB)